Phenotypic and genotypic characterization of macrolide resistant Streptococcus pneumoniae recovered from adult patients with community-acquired pneumonia in an Argentinian teaching hospital

Int J Antimicrob Agents. 2005 Mar;25(3):260-3. doi: 10.1016/j.ijantimicag.2004.10.011. Epub 2005 Jan 21.

Abstract

Streptococcus pneumoniae isolates (n = 262) were recovered from adult patients with community-acquired pneumonia. Erythromycin-resistance levels increased from 9% (1997-1998) to 16% (2000-2002). Sampling for resistance mechanisms prevalent within 19 erythromycin-resistant S. pneumoniae showed mef(E) in 13/19 isolates while 4/19 carried the erm(B) gene (3/19 cMLS(B) and 1/19 iMLS(B) phenotype). MIC ranges for erythromycin and clindamycin were 0.5-16 mg/l and <0.008-0.063 mg/l for the M phenotype, 128-512 mg/l and 128-256 mg/l for the cMLS(B) phenotype, and 4 and <0.008 mg/l for the iMLS(B) phenotype. This is the first report studying the prevalence of macrolide resistance determinants in S. pneumoniae in our country.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Anti-Bacterial Agents / pharmacology*
  • Argentina
  • Bacterial Proteins / genetics
  • Clindamycin / pharmacology
  • Community-Acquired Infections / microbiology*
  • Drug Resistance, Bacterial / genetics*
  • Erythromycin / pharmacology
  • Genes, Bacterial
  • Genotype
  • Hospitals, Teaching
  • Humans
  • Macrolides / pharmacology*
  • Membrane Proteins / genetics
  • Methyltransferases / genetics
  • Microbial Sensitivity Tests
  • Pneumonia, Pneumococcal / microbiology*
  • Streptococcus pneumoniae / drug effects*
  • Streptococcus pneumoniae / genetics
  • Streptococcus pneumoniae / isolation & purification

Substances

  • Anti-Bacterial Agents
  • Bacterial Proteins
  • Macrolides
  • MefE protein, Streptococcus pneumoniae
  • Membrane Proteins
  • Clindamycin
  • Erythromycin
  • ErmTR protein, bacteria
  • Methyltransferases